Arthroscopic ACL reconstruction with peroneus longus graft with or without a platelet-rich plasma (PRP) injection
Official title: Comparison of Functional Outcomes Following Arthroscopic ACL Reconstruction With Peroneus Longus Autograft With and Without Intra-articular Platelet-Rich Plasma Injection: A Randomized Controlled Trial
Run by Lahore General Hospital · NCT07470359 · Data updated 2026-11-12
This test sees if a single 4 ml intra-articular PRP injection given during ACL reconstruction with a peroneus longus graft helps adults (18–50) with isolated ACL tears recover better over 12 months.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Lahore General Hospital Government |
| Locations | 1 site (Lahore, Punjab Province) |
| Status | Recruiting |
| Started | February 20, 2026 |
| Main results expected | August 31, 2027 |
| Study ends | November 30, 2027 |
| Registry record updated | March 13, 2026 |
| Trial ID | NCT07470359 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–50 with a primary, complete isolated ACL tear planning arthroscopic reconstruction with a peroneus longus autograft who are active in sports or regular physical activity and can attend follow-up visits are ideal candidates.
✕Probably not a fit
Patients with prior surgery on the affected knee, multi-ligament injuries, significant cartilage damage or knee osteoarthritis, systemic inflammatory disease, bleeding disorders, current anticoagulant use, or recent intra-articular corticosteroid injection are excluded and unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center, prospective randomized controlled Phase 2 trial in Lahore, Pakistan will randomize 88 adults with isolated complete ACL tears to receive either a single 4 ml intra-articular PRP injection or saline at the time of arthroscopic ACL reconstruction with a peroneus longus autograft. PRP is prepared from 15–20 ml venous blood using a single-spin centrifugation (3500 rpm) and delivered as 2 ml per femoral/tibial tunnel during surgery. Functional recovery will be measured using KOOS4 questionnaires at baseline, 3, 6, and 12 months with primary comparisons made by ANCOVA adjusting for baseline scores. The trial is designed to be feasible in a resource-limited setting and integrates follow-up into routine clinic visits to minimize dropout.
Why it matters
Potential benefit: If successful, adding a single PRP injection could improve knee function and speed recovery after ACL reconstruction with peroneus longus grafts while remaining affordable for resource-limited settings.
How similar studies have gone: Prior ACL reconstruction studies of PRP have reported mixed results with some signs of improved graft healing and function, but findings are inconsistent and PRP use specifically with peroneus longus autografts is not well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Age between 18 and 50 years. Diagnosis of a primary, complete ACL tear requiring reconstruction. Willingness to undergo arthroscopic ACL reconstruction with peroneus longus autograft. Active individuals participating in sports or regular physical activity. Willingness to provide informed consent and adhere to the study protocol, including follow-up visits and rehabilitation. Ability to understand and complete study questionnaires. - Exclusion Criteria: Previous knee surgery on the affected limb. Concomitant ligamentous injuries requiring additional reconstruction (e.g., PCL, MCL, LCL Grade III). Significant chondral damage (Outerbridge grade \> 2 on pre-operative MRI or intra-operative assessment). Pre-existing knee osteoarthritis (Kellgren-Lawrence grade \> 2). Systemic inflammatory conditions (e.g., rheumatoid arthritis). Bleeding disorders or coagulopathies. Current use of anticoagulants. Corticosteroid injection into the knee within 6 weeks prior to surgery. Pregnancy or lactation. Inability to comply with the rehabilitation protocol. Infection or history of infection in the affected knee. History of previous contralateral ACL injury (to isolate primary injury outcomes). \-
Where it's running
-
Lahore General Hospital
Lahore, Punjab Province, Pakistan Recruiting
Study contacts
- Study coordinator: Hafiz Sohail Ahmad, Dr
- Email: Hafiz.sohail.315@gmail.com
- Phone: +923204085069
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Plyometric training added to standard rehab after ACL reconstruction
This study tests whether adding plyometrics to the usual rehab after ACL reconstruction helps improve leg strength and function in adults aged 18–40.
-
Isokinetic vs Plyometric Training After ACL Reconstruction
This trial tests whether isokinetic or plyometric training, added after standard rehab, best improves strength, function, and patient-reported outcomes in adults 18–40 after ACL reconstruction.
-
ACL reconstruction using the Over-The-Top technique with either metal staples or soft anchors
This study tests whether using a suture-based fixation (soft anchors) during OTT ACL reconstruction works as well as metal staples for graft stability in adults aged 18–50.
-
Botulinum toxin vs hyaluronic acid injections for knee osteoarthritis
This study tests whether injecting botulinum toxin or hyaluronic acid directly into the knee provides better pain relief for people with knee osteoarthritis.
-
Arthrosamid versus steroid injections for managing knee osteoarthritis.
This trial will test whether a single Arthrosamid hydrogel injection works better than a standard steroid plus local anesthetic injection for adults with symptomatic knee osteoarthritis.
-
Movement-related fear after ACL reconstruction: general kinesiophobia versus task-specific sport fear
This trial will test whether visual and imagined movement exposures reveal task-specific fear versus general kinesiophobia in people aged 18–35 recovering from ACL reconstruction.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.